Lv31
400 积分 2025-08-15 加入
Technical Report No. 64: Active Temperature-Controlled Systems: Qualification Guidance
34分钟前
求助中
Technical Report No. 64: Active Temperature-Controlled Systems: Qualification Guidance
43分钟前
已关闭
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
2个月前
已完结
Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo
3个月前
已完结
Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach
3个月前
已完结
Optimal two-stage designs for phase II clinical trials
8个月前
已完结
追踪国外六大监管机构获批药品在中国的可及性
8个月前
已关闭
论药品监管指导原则的法律渊源与法律运用
8个月前
已完结
皖公网安备34019202002308
